NM_014254.3:c.252C>T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_014254.3(RXYLT1):​c.252C>T​(p.Ser84Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00204 in 1,608,766 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0014 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0021 ( 8 hom. )

Consequence

RXYLT1
NM_014254.3 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: -0.518

Publications

2 publications found
Variant links:
Genes affected
RXYLT1 (HGNC:13530): (ribitol xylosyltransferase 1) This gene encodes a type II transmembrane protein that is thought to have glycosyltransferase function. Mutations in this gene result in cobblestone lissencephaly. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, May 2013]
RXYLT1 Gene-Disease associations (from GenCC):
  • muscle-eye-brain disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 10
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 12-63781101-C-T is Benign according to our data. Variant chr12-63781101-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 195295.
BP7
Synonymous conserved (PhyloP=-0.518 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00138 (210/152108) while in subpopulation NFE AF = 0.00249 (169/68008). AF 95% confidence interval is 0.00218. There are 1 homozygotes in GnomAd4. There are 86 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 8 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RXYLT1NM_014254.3 linkc.252C>T p.Ser84Ser synonymous_variant Exon 2 of 6 ENST00000261234.11 NP_055069.1 Q9Y2B1
RXYLT1XM_047428079.1 linkc.252C>T p.Ser84Ser synonymous_variant Exon 2 of 5 XP_047284035.1
RXYLT1NM_001278237.2 linkc.-529C>T 5_prime_UTR_variant Exon 2 of 6 NP_001265166.1 Q9Y2B1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RXYLT1ENST00000261234.11 linkc.252C>T p.Ser84Ser synonymous_variant Exon 2 of 6 1 NM_014254.3 ENSP00000261234.6 Q9Y2B1

Frequencies

GnomAD3 genomes
AF:
0.00138
AC:
210
AN:
152108
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000435
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00104
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00248
Gnomad OTH
AF:
0.000959
GnomAD2 exomes
AF:
0.00116
AC:
287
AN:
246960
AF XY:
0.00122
show subpopulations
Gnomad AFR exome
AF:
0.000500
Gnomad AMR exome
AF:
0.000270
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00107
Gnomad NFE exome
AF:
0.00212
Gnomad OTH exome
AF:
0.00150
GnomAD4 exome
AF:
0.00211
AC:
3077
AN:
1456658
Hom.:
8
Cov.:
30
AF XY:
0.00209
AC XY:
1516
AN XY:
724594
show subpopulations
African (AFR)
AF:
0.000301
AC:
10
AN:
33230
American (AMR)
AF:
0.000343
AC:
15
AN:
43782
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26036
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39258
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85180
European-Finnish (FIN)
AF:
0.00101
AC:
54
AN:
53310
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5744
European-Non Finnish (NFE)
AF:
0.00263
AC:
2917
AN:
1109966
Other (OTH)
AF:
0.00133
AC:
80
AN:
60152
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
146
292
439
585
731
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
116
232
348
464
580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00138
AC:
210
AN:
152108
Hom.:
1
Cov.:
33
AF XY:
0.00116
AC XY:
86
AN XY:
74302
show subpopulations
African (AFR)
AF:
0.000435
AC:
18
AN:
41426
American (AMR)
AF:
0.000655
AC:
10
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5200
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00104
AC:
11
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.00248
AC:
169
AN:
68008
Other (OTH)
AF:
0.000959
AC:
2
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
11
22
32
43
54
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00158
Hom.:
0
Bravo
AF:
0.00123

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:4
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RXYLT1: BP4, BP7 -

Jun 01, 2015
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 13, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
4.7
DANN
Benign
0.60
PhyloP100
-0.52
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141095352; hg19: chr12-64174881; API